Red List

TMDXTransMedics Group, Inc.

Healthcare · Medical Devices · mid-cap ($2.6B)
-47.3%
from rolling 252-day high of $156.00 set 2025-12-02 · 285d ago
Current
$82.18
Decline depth
-47.3%
Decline σ
6.1σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$TMDX landed on the list 2026-03-14, down 20.1% from its 52-week high that day — now down -47.3%.

That's 27.2 percentage points deeper than the day it joined. It bottomed 60.2% below that high along the way.

From the 52-week high as of 2026-03-16 to today. Split-adjusted. Observed, not a forecast.

Structural break signals

TMDX qualifies for the Red List on decline depth.

Decline depth
-47.3%
From rolling 252-day high of $156.00, 285d ago. Past the 40% Red List threshold.
Time-frame continuity
3/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3. Past the 3/5 Watch threshold.
Decline sigma
6.1σ
Drop over the last 20 bars in units of daily volatility (2.72%/day). Past the ≥6σ Amber threshold.

The structural read

What price action says about TMDX.

TMDX qualifies for the Red List on decline depth — down -47.3% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Cross-confirmation: also showing 3/5 bearish time frames.

Cross-confirmation: decline sigma also reads 6.1σ over 20 bars.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2D (red), monthly 1 (red).

Earnings on file: 2026-08-04. Earnings dates don't affect tiering.

Questions about TMDX

What people ask.

Why is TMDX on Broken Stocks?

TMDX qualifies for the Red List on decline depth. It is down -47.3% from its rolling 252-day high of $156.00, set on 2025-12-02 — 285d ago.

Is TMDX a falling knife?

Not by the strict technical definition. TMDX is down -47.3% from its 52-week high, but that high was set 285d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. TMDX is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is TMDX a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is TMDX trading inside its 52-week range?

At $82.18, TMDX sits 23.0% of the way from its 52-week low ($60.10) to its 52-week high ($156.00). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has TMDX been declining?

The current 47.3% decline accrued over 285d, which annualizes to roughly -60.6% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does TMDX compare to its sector?

There are 267 other Healthcare tickers on Broken Stocks: 146 Red, 82 Amber, 39 Watch, with 27 showing recovering structural signals. Median sector decline is -36.7% — TMDX's decline is deeper than the sector median.

Does TMDX's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-08-04) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.